Influence of waist on adiponectin and insulin sensitivity in adolescence

Obesity

Volumn 17, Issue 1, 2009, Pages 156-161

  Rasmussen Torvik, Laura J ^a   Pankow, James S ^a   Jacobs, David R ^a,b   Steinberger, Julia ^c   Moran, Antoinette M ^c   Sinaiko, Alan R ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ABDOMEN; ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CAUCASIAN; CHILD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HISTOLOGY; HUMAN; INSULIN RESISTANCE; MALE; NEGRO; RISK FACTOR; WAIST CIRCUMFERENCE;

ABDOMEN; ADIPONECTIN; ADOLESCENT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; RISK FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 57949104769     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.482     Document Type: Article

References (39)

1. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in mexican-americans. Diabetes 1995;44:1386-1391.
2. Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians. N Engl J Med 1993;329:1988-1992.
3. Skarfors ET, Selinus KI, Lithell HO. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 1991;303:755-760.
4. Charles MA, Fontbonne A, Thibult N et al. Risk factors for NIDDM in white population. Paris prospective study. Diabetes 1991;40:796-799.
5. Andersen LB, Boreham CA, Young IS et al. Insulin sensitivity and clustering of coronary heart disease risk factors in young adults. The northern Ireland young hearts study. Prev Med 2006;42:73-77.
6. Frayn KN. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad. Med Princ Pract 2002;11(Suppl 2):31-40.
7. Park SH, Lee WY, Lee YS, Rhee EJ, Kim SW. The relative effects of obesity and insulin resistance on cardiovascular risk factors in nondiabetic and normotensive men. Korean J Intern Med 2004;19:75-80.
8. Tataranni PA, Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 2005;54:917-927.
9. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-355.
10. Krakoff J, Funahashi T, Stehouwer CD et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the pima indian. Diabetes Care 2003;26:1745-1751.
11. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005;6:13-21.
12. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
13. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
14. Lihn AS, Bruun JM, He G et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15.
15. Park KG, Park KS, Kim MJ et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-142.
16. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-353.
17. Steffes MW, Gross MD, Schreiner PJ et al. Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004;14:492-498.
18. Tschritter O, Fritsche A, Thamer C et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-243.
19. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
20. Chen L, Xiang KS, Jia WP et al. Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study. Zhonghua Yi Xue Za Zhi 2005;85:1456-1459.
21. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469.
22. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004;27:1699-1705.
23. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-3794.
24. Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006;148:188-194.
25. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004;27:547-552.
26. Caprio S, Hyman LD, Limb C et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995;269:E118-E126.
27. Lee S, Bacha F, Gungor N, Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006;29:51-56.
28. Sinaiko AR, Jacobs DR Jr, Steinberger J et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001;139:700-707.
29. Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3-19 y. Am J Clin Nutr 2000;72:490-495.
30. Slaughter MH, Lohman TG, Boileau RA et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988;60:709-723.
31. Steinberger J, Jacobs DR, Raatz S et al. Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. Int J Obes (Lond) 2005;29:1346-1352.
32. Meng X, Rosenthal R, Rubin D. Comparing correlated correlation coefficients. Psychol Bull 1992;111:172-175.
33. Yatagai T, Nagasaka S, Taniguchi A et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003;52: 1274-1278.
34. Kriketos AD, Carey DG, Jenkins AB et al. Central fat predicts deterioration of insulin secretion index and fasting glycaemia: 6-year follow-up of subjects at varying risk of type 2 diabetes mellitus. Diabet Med 2003;20:294-300.
35. Sites CK, Calles-Escandon J, Brochu M et al. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 2000;73:61-65.
36. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-1585.
37. Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005;54:2772-2778.
38. Rasmussen-Torvik LJ, Pankow JS, Jacobs DR et al. Heritability and genetic correlations of insulin sensitivity measured by the euglycaemic clamp. Diabet Med 2007;24:1286-1289.
39. Schwartz B, Jacobs DR Jr, Moran A et al. Measurement of insulin sensitivity in children: comparison between the euglycemic hyperinsulinemic clamp and surrogate measures. Diabetes Care 2008;31:783-788.